TY - JOUR
T1 - Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation
T2 - Dawn of a new era
AU - Contractor, Tahmeed
AU - Levin, Vadim
AU - Martinez, Matthew W.
AU - Marchlinski, Francis E.
N1 - Funding Information:
This work was supported in part by the F. Harlan Batrus and Murray and Susan Bloom Research Funds at the University of Pennsylvania, Philadelphia, PA.
PY - 2013/1
Y1 - 2013/1
KW - Apixaban
KW - Atrial fibrillation
KW - Dabigatran
KW - Edoxaban
KW - Oral anticoagulants
KW - Rivaroxaban
KW - Administration, Oral
KW - Humans
KW - Risk Factors
KW - Morpholines/administration & dosage
KW - Pyrazoles/administration & dosage
KW - Stroke/etiology
KW - beta-Alanine/administration & dosage
KW - Anticoagulants/administration & dosage
KW - Pyridones/administration & dosage
KW - Thiophenes/administration & dosage
KW - Atrial Fibrillation/complications
KW - Benzimidazoles/administration & dosage
UR - https://www.scopus.com/pages/publications/84875904016
UR - https://www.scopus.com/pages/publications/84875904016#tab=citedBy
UR - https://www.mendeley.com/catalogue/7e282fd1-01b7-3b51-8464-45398a3a192d/
U2 - 10.3810/pgm.2013.01.2622
DO - 10.3810/pgm.2013.01.2622
M3 - Review article
C2 - 23391669
AN - SCOPUS:84875904016
SN - 0032-5481
VL - 125
SP - 34
EP - 44
JO - Postgraduate Medicine
JF - Postgraduate Medicine
IS - 1
ER -